Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 69.07 ▲ 0.01 (0.01%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Merck & Company (New) | MRK | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.21 | +0.31% | 69.06 | 69.235 | 68.7 | 68.78 | 68.85 | 18:03:24 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 47,785 | 7,847,116 | $ 69.0136 | $ 541.56M | 7.75M | 52.83 - 69.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:40:25 | 88 | $68.90 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Merck & Company (New) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 183.67B | 2.66B | $ 2.39B | 0.88 | 0.00 | 2.69B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.92 | 2.78% | 09/14/2018 | -50.68k | 77.60% |
Merck & Company (New) News
Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellu... PR Newswire (US) • Fri Aug 17, 2018 8:00 AM (2 days ago)
Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes ... PR Newswire (US) • Fri Aug 17, 2018 8:00 AM (2 days ago)
Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellu... PR Newswire (US) • Thu Aug 16, 2018 4:11 PM (3 days ago)
Quarterly Report (10-q) Edgar (US Regulatory) • Tue Aug 07, 2018 4:38 PM (2 weeks ago)
Merck’s Head of Human Resources Mirian M. Graddick-Weir to Retire; Steven C. Mizell Will Assume Role on Oct. 1 Business Wire • Tue Aug 07, 2018 4:30 PM (2 weeks ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Mon Aug 06, 2018 4:51 PM (2 weeks ago)
Merck, AstraZeneca Get EMA Orphan Designation for Selumetinib Dow Jones News • Fri Aug 03, 2018 10:41 AM (2 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 65.9 | 69.235 | 65.68 | 67.5328 | 5M | 17M | 9M | 3.16 | 4.80% |
| 1 Month | 62.06 | 69.235 | 62.005 | 65.6855 | 5M | 17M | 8M | 7 | 11.28% |
| 3 Months | 59.14 | 69.235 | 58.025 | 62.7703 | 4M | 19M | 9M | 9.92 | 16.77% |
| 6 Months | 55.97 | 69.235 | 52.83 | 59.0443 | 4M | 23M | 10M | 13.09 | 23.39% |
| 1 Year | 61.77 | 69.235 | 52.83 | 58.9220 | 4M | 48M | 10M | 7.29 | 11.80% |
| 3 Years | 56.59 | 69.235 | 45.69 | 58.4095 | 3M | 69M | 9M | 12.47 | 22.04% |
| 5 Years | 47.98 | 69.235 | 44.62 | 57.1215 | 3M | 69M | 10M | 21.08 | 43.93% |
Merck & Company (New) Description
| Merck & Co Inc is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. |
